The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

Moderna Inc. gained US approval for a new Covid vaccine for a narrower group of people, in the latest sign that regulators ...

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

The U.S. Centers for Disease Control and Prevention is still recommending COVID-19 vaccines for healthy children, according ...

HHS has terminated contracts with Moderna worth more than $700 million that were meant to fund the company’s development of ...

The Health and Human Services Department, led by vaccine skeptic Robert F. Kennedy Jr., has canceled $766 million in payments ...

But some insurers and employers may decide to still cover the shots regardless of the new recommendations, said Jen Kates, a ...

A new variant of COVID-19 is circulating in parts of the world and may be driving an increase in cases in the eastern ...

We recently published a list of Jim Cramer Talked About These 13 Stocks. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks that Jim Cramer ...